BNP Paribas Financial Markets’s ClearPoint Neuro CLPT Stock Holding History

BNP Paribas Financial Markets’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$159K	Buy	8,928 +2,931	+49%	+$36.6K	﹤0.01%	4333
2026 Q1	$54.6K	Buy	5,997 +259	+5%	+$3.27K	﹤0.01%	4647
2025 Q4	$78.5K	Sell	5,738 -104,763	-95%	-$1.94M	﹤0.01%	4476
2025 Q3	$2.41M	Buy	110,501 +108,270	+4,853%	+$1.28M	﹤0.01%	2492
2025 Q2	$26.6K	Buy	2,231 +2,143	+2,435%	+$27K	﹤0.01%	4485
2025 Q1	$1.05K	Sell	88 -13	-13%	-$202	﹤0.01%	5064
2024 Q4	$1.55K	Buy	+101	New	+$1.31K	﹤0.01%	5037

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BNP Paribas Financial Markets's CLPT Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its ClearPoint Neuro (CLPT) stake by 49% in Q2 2026, buying an estimated $36.6K and bringing the position to 8,928 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #4333.

BNP Paribas Financial Markets first reported a position in CLPT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.41M in Q3 2025. 121 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

BNP Paribas Financial Markets held 8,928 shares of ClearPoint Neuro worth $159K as of Q2 2026.
BNP Paribas Financial Markets bought 2,931 ClearPoint Neuro shares in Q2 2026, an estimated $36.6K.
ClearPoint Neuro made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4333 holding.
BNP Paribas Financial Markets first reported a position in ClearPoint Neuro in Q4 2024 and has held it in 7 quarters since.
BNP Paribas Financial Markets's ClearPoint Neuro position peaked at $2.41M in Q3 2025.
121 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.